Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I do not post much b/c of the banter that exist on ihub boards. Ive been here since it was DEGH and have not sold a single share that I bought @.01 in Jan 2011. But, you are absolutely right about it not acting like a typical pink, however the people tend to trade it as such,like buy on rumor sell on news. I know people will ask me why haven't you sold, well b/c my initial investment has been made elsewhere and I feel this is just a free investment that may be a golden ticket down the road. But I can honestly say that FUSE has done everything they said they were going to do. The fact that they have done so much in the past year and half is amazing. I don't know what people expect with the economy as it is.
Glad to see you still hanging around. Been deployed for quite sometime. Still have all 175000 original shares at a penny or so. Seen the last spike to 1.25$ but was playing defend the united states. hope you made money. Still Long in DROP.
I see your still hanging around. Good to see some of the original players still here. Don't really bother with boards but I see I can still get a good laugh from you. Still long in DROP, on the advice of wifey of course. She has big plans for the money; Me = no more workey, workey. So I guess I can't complain.
Good to see you here and GLTA.
Go DROP, I want to retire soon.
Still here as well from January but haven't sold any of the 175,000 shares I have. Made money in other stocks that this is like riding free shares.
GLTA
Idk,
It's just hard to think two companies in the same industry with names so similar. Gulf coast oil and gas or gulf coast oil and natural gas.
Huge News out!!!!!!!!!
Encore Energy Partners LP Acquires Gulf Coast Oil and Natural Gas Properties and Completes Acquisition of Wyoming Oil and Natural Gas Properties. HOUSTON--(BUSINESS WIRE)-- Encore Energy Partners LP (NYSE:ENP - News) (the “Partnership” or “ENP”) today announced that on August 31, 2011 it closed on the acquisition of certain non-operated working interests in mature producing oil and natural gas assets in the Texas and Louisiana Gulf Coast area from an undisclosed seller for a purchase price of $47.6 million after consideration of preliminary purchase price adjustments. The assets acquired have estimated total proved reserves of 2.1 million barrels of oil equivalent, of which approximately 83% are oil and natural gas liquids reserves. The reserves are 100% proved developed and the current net production attributable to the assets being acquired is approximately 430 Boe/d. Effective date of this acquisition was August 1, 2011.
In addition, on September 1, 2011, ENP closed the previously announced acquisition of non-operated producing oil and natural gas assets in Sweetwater County, Wyoming from an undisclosed seller for a purchase price of $28.2 million after consideration of preliminary purchase price adjustments. The properties acquired by ENP have estimated total net proved reserves of 4.2 million barrels of oil equivalent, of which approximately 65% are natural gas reserves and 35% are oil and natural gas liquids reserves. The reserves are 90% proved developed and the current net production attributable to the assets being acquired is approximately 880 Boe/d. The effective date of the acquisition was June 1, 2011.
In conjunction with these acquisitions, ENP has entered into new oil and natural gas hedges covering a substantial portion of the estimated production related to the proved developed reserves from these acquisitions for the next several years.
Just seems like a waste of time for someone to invest a whole 30 dollars for 100 shares and pay a 6.95 to 9.99 commission fee to do so. Spend 33% of the cost to buy something. even scalping DEGH for one or two upticks takes profit in commissions.
Your absolutely right. That's why I also think something is up when you seen low volume with DEGH and it has these types of trades.I think they want cheap shares and can shake them out of people when volume is low. Im long in DEGH and have been in since .009.
Got this off another board on I-Hub. People seem to think the mm's signal each other during trading. It makes sense because I have seen 100 signals on .0001 stock. Now either you have nothing better to do then by .10 cent worth of stock and pay commission fees to do it or there is some truth to this.
Notice how small some of the trades have been on DEGH recently. Mostly these amounts.
MM SIGNALS:
100= I need shares.
200= I need shares badly,but do not take the stock down.
300= Take the price down so I can load shares
400= Keep trading it sideways.
500= Gap the stock. This gap can be either up or down, depending on the direction of the 500 signal.
Hope it helps.
News out
DEGH has retained former president and CEO of Champs Sports as a consultant to lead the companys licensing and acquisitions efforts.
News Out
Baltimore Ravens, rookie receiver Torrey Smith powered by Fuse. 2011 NFL 2nd round draft pick.
I was told when this occurs they are shorting shares. That's why they haven't moved yet.
News out
Texas Oil and Minerals CEO Issues an Open Letter to Shareholders
HOUSTON, Aug. 18, 2011 /PRNewswire via COMTEX/ -- Texas Oil and Minerals, Inc. (OTC Pinksheets: BNPD) today issued a letter to shareholders from the company's CEO, Tom Gouger. www.texasoilandmineralsinc.com
Dear Fellow Shareholders,
Since creating Texas Oil and Minerals, I have focused our talented team on executing our ambitious business plan. As a result of these efforts, we have experienced accelerated growth.
As a public company, the facts of our success in growing our company have been well documented. Unfortunately, in the modern age of the internet, message boards and blogs allow for the rapid and broad dissemination of information on companies whether the information is factual or not. In light of the recent activity and concerns, it is important to set the record straight about Texas Oil and Minerals.
Since becoming CEO, I have been focused on building long-term shareholder value and reporting to our shareholders in a manner that is transparent, accurate and in compliance with all applicable laws, SEC regulations, and stock exchange rules. During our transition from a private to a publicly reporting company quoted in the over the counter, we have taken what I believe to be all the logical steps to support our company growth.
While this transition has been time consuming and difficult, our objectives will be reached. The truth is we are making necessary improvements despite the short-term pain and expect to receive a letter from FINRA informing us that they have approved the symbol and name change sometime next week.
What we find most disturbing in the attack blog is its use of divisive, deceptive, and manipulative means for its own short-term gains at the expense of our shareholders.
About Texas Oil and Minerals (BNPD)
Texas Oil and Minerals creates value by acquiring and exploiting reserves in fields specifically targeted for oil and high-rate return North American clean burning natural gas. We are involved in prospects that range in value from $1,000,000 to $50,000,000, which include seismic and land projects, drilling prospects and the purchase of producing properties. Our team is comprised of highly skilled industry professionals who leverage their knowledge toward the success of our business. With more than three generations of collective experience, this team of professional and talented production personnel can provide innovative exploration and development solutions focused on creating exceptional returns in oil and gas through acquisition and exploration. www.texasoilandmineralsinc.com
Safe Harbor Statement:
This release includes forward-looking statements intended to qualify for the safe harbor from liability established by the Private Securities Litigation Reform Act of 1995. These forward-looking statements generally can be identified by phrases such as INCL or its management "believes," "expects," "anticipates," "foresees," "forecasts," "estimates" or other words or phrases of similar import. Similarly, statements herein that describe the Company's business strategy, outlook, objectives, plans, intentions or goals also are forward-looking statements. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking.
Stock Logiq Corp.
Robert Adams, 877-648-0004
info@stocklogiq.com
www.stocklogiq.com
SOURCE Texas Oil and Minerals, Inc.
www.prnewswire.com
News Out!
DEGH is looking for money in all the "right" places.
AVENTURA, Fla., Aug. 15, 2011 /PRNewswire/ -- Double Eagle Holdings, Ltd (OTCQB: DEGH), announced today that it has retained National Securities Corporation as the company's exclusive investment banker to lead the company's next round of capitalization, as well as possible acquisition and strategic alliance transactions. Double Eagle Holdings is the parent company of Fuse Science, Inc. (www.fusescience.com), the developer of new, proprietary technologies poised to redefine how consumers receive energy, medicines, vitamins and minerals.
Founded in 1947, National Securities Corporation is an international full service independent brokerage firm with a diverse base of retail and institutional clients. National Securities was founded in 1947 in Seattle, Washington with the goal of providing a full suite of financial products and services to its registered representatives and clients. National Securities and its subsidiaries are headquartered in New York City and Seattle and have a multitude of domestic and international offices that provide a broad range of securities brokerage, financial planning, and investment services, as well as corporate finance and investment banking services to corporations and businesses. The company operates in more than 70 locations throughout the United States and Europe through some 800 Registered Representatives.(www.nationalsecurities.com/investmentbanking.php)
Fuse Science just recently announced its strategy to advance its technology through several major categories ranging from energy drinks to aspirin and from vitamins to major pharmaceutical applications in partnership with the New England Consulting Group.
"We believe in recruiting the best for all facets of our business, and National Securities is a proven leader in working with emerging growth companies," added Brian Tuffin, Fuse Science President and Chief Operating Officer. "As an immediate priority, the National Securities team will lead our company's next round of financing, which will fully capitalize operations through our next stage of growth and allow us to bring Fuse Science's ground-breaking technology to market."
Ok Ill ask that question too: why don't they give Jeremy 51% interest in the company?; do a merger with Bodybuilding.com so harrypalms and I can sell our shares at 2 buxxxxxx
this wasn't directed at anyone, sorry JAG. Is it just me, or are the expectations of this company like that of a big board stock. You don't want dilution, you mad at convertibles being cashed in, but you want to see commercials, You want big name sports athletes off the jump, at the expense of who? you want to see the product on the shelves in Walmart, Target, CVS, Rite_Aid, Walgreens, Sears and every other retailer under the sun.
I think this stock is holding well for no products on the shelves. Be careful what you wish for, Im in another stock and others are too on this board and its face is everywhere in its particular industry but the stock is not reflecting the perceived success.
So If your looking for quick gains and the usual pink pr bs spike in price and fall back to where it was before then DEGH may not be what your looking for and this is all in my opinion.
Just food for thought.
Thanks
Question: If Jeremy Deluca is " chief Marketing Officer" with MP, isn't that a conflict of interest?
Is there another independent company, website that boasts the same thing about MP that have no vested interest?
Jeremy Deluca
Co-President and Chief Marketing Officer
Jeremy DeLuca was the co-founder and President of Bodybuilding.com. He was involved in all aspects of the business but his primary focus was on the Marketing, Sales, and e-commerce (on-line store). His teams managed all vendor relations, marketing and sales promotions, store content, store site development, etc. Jeremy achieved amazing success with Bodybuilding.com, starting from the garage and being a major role taking the company to over $200,000,000.00 in sales.
Bodybuilding.com boasts impressive numbers and ranking with these achievements:
* Most Visited Bodybuilding And Fitness Site In The World
* #1 Sports Nutrition E-Retailer
* 2-Time Inc. 500 Company 2005-2006
* Ranked Number 768 On Alexa's Most Visited Web Sites
* 300,000+ Unique Daily Visitors
* World's Largest Online Fitness Community
* One of America's Top 500 E-Retailers, and;
* One of the Top 75 Largest Private Companies in the State Of Idaho
I am a shareholder but would love to see this go outside the realm of bodybuilding.com and MP stroking their own packages.
News out!!!!!!
Board has approved a R/S for 5000 to 1 reverse split. Its on TD ameritrade.
Well you can be the new spokeperson for FUSE. " Crossball's lit by Fuse" for those who like it "FAST AND ROUGH".
Yeah had to learn real quick what stocks moved on news and the ones that didn't. I almost traded myself out of this one when R/M news hit and it didn't move. DEGH is not your normal penny stock. You said yourself DEGH likes to show her legs, but I think it' only when " no one looking and you have some money to spend".
This is one penny stock that just doesn't move on news.
News out!!!!!!!!
Defense Trio
Paul Soliai, Shawn Smith, Nolan Carroll.
contract cont.
(b) This Agreement may also be terminated by MusclePharm, upon five day’s prior written notice, if death, disability, physical injury, or other incapacity causes Endorser to be unable to perform a material amount of the personal or consulting services described in this Agreement. Upon termination by MusclePharm because of death, disability, physical injury, or other incapacity, the rights to use Endorser’s Name and Appearance will immediately be revoked with no “use-up period” unless agreed to in a separate written agreement executed by MusclePharm and either the Endorser or the Endorser’s heirs. If Endorser has performed all services required by this Agreement, MusclePharm will be obligated to compensate Endorser or Endorser’s heirs with the full compensation amount of this Agreement.
(c) Upon any termination of this Agreement, for any reason, MusclePharm shall not be liable to pay any compensation for services performed after the termination and Endorser shall not be obligated to perform any services after the date of a termination notice. If Endorser has performed all services required by this Agreement, then upon termination, MusclePharm shall pay the full compensation amount of this Agreement.
9. Expenses: MusclePharm shall pay first-class travel and lodging expenses for Endorser and one (1) guest. Endorser shall be reimbursed for additional expenses that are necessarily incurred in connection with services requested by MusclePharm. MusclePharm’s obligation to reimburse Endorser pursuant to this paragraph shall be subject to the presentation of an itemized account of such expenditures, together with supporting receipts or invoices, for any expenditure in excess of $50.00. In order to obtain reimbursement for any expense in excess of $500.00, Endorser shall obtain MusclePharm’s prior written approval before incurring the expense, notwithstanding any other provision in this paragraph.
10. Independent Contractor: It is expressly agreed that Endorser is acting as an independent contractor in performing his services hereunder. MusclePharm shall carry no worker's compensation insurance or any health, accident or disability insurance to cover Endorser. MusclePharm shall not pay any contributions to Social Security, unemployment insurance, federal or state withholding taxes, nor provide any other contributions or benefits that might be expected in an employer-employee relationship. Endorser shall be solely responsible and liable for reporting and paying all federal and state income or other taxes applicable to the Endorser’s compensation under this Agreement, and MusclePharm will provide Endorser with an IRS Form 1099 at the end of each calendar year in which compensation is paid to Endorser. It is further understood and expressly agreed by Endorser that he has no right or authority to incur expenses, obligations or liabilities in the name of or binding on MusclePharm, and he shall not represent to third parties that he has any relationship (e.g., employer-employee or principal-agent) with MusclePharm other than the independent contractor arrangement set forth in this Agreement.
11. Indemnification: Each party agrees to indemnify and hold the other harmless from and against any and all demands, claims or actions for loss, damage, or liability, including but not limited to loss of use of property, personal injury, illness or death, suffered by any person where such loss, damage, liability, injury, illness or death is proximately caused by negligence of one party or the other, or by a material breach or default under this Agreement. In the event the parties’ acts or omissions jointly cause loss, damage or liability, the parties shall be comparatively responsible for any such loss, damage or liability in proportion to their comparative liability for the claimant’s loss or injury. Furthermore, MusclePharm agrees to indemnify Mike Vick against any and all claims made by consumers and users of its products.
12. Non-Competition: During the term of this Agreement, or any extensions of this Agreement, the Endorser shall not use, advertise, promote or endorse the supplements or products of any company other than MusclePharm, either directly or indirectly:
(a) Endorser shall not advise, assist, perform services for, consult with or participate, as an endorser, agent, representative, director, officer, employee, member, or partner with any person or entity engaged in a business that competes directly or indirectly with the business of MusclePharm unless required or incidental to Endorser’s employment in the NFL.
(b) Endorser shall not use or provide endorsements or testimonials for products that compete with MusclePharm Products.
Any failure of Endorser to disclose such conflicting interests, or any breach of this paragraph, shall be deemed a material breach of the Agreement. Endorser’s duty not to compete with the business of MusclePharm shall continue for a period of six months following the expiration or termination of this Agreement. Endorser’s non-competition obligation shall not be required in the event of a material breach of this Agreement by MusclePharm.
13. Conduct: This Agreement is for Endorser's personal services and at all times Endorser shall conduct himself with due respect for social conventions and decency, and Endorser shall not engage willfully in any act or conduct or willfully become involved in situations or occurrences which in MusclePharm’s sole judgment reflect unfavorably upon Endorser, or MusclePharm, its business or its Products, or which result in Endorser being convicted of a crime or otherwise coming into public disrepute. Endorser shall exercise self-conduct in such a manner so as to enhance the image and reputation of MusclePharm and its Products. MusclePharm shall have the right to terminate this Agreement immediately if Endorser engages in any act or conduct described in this paragraph.
14. Assignment: This Agreement is for the personal services of the Endorser and is entered into in reliance upon and in consideration of the reputation and celebrity of Endorser. Endorser shall therefore not voluntarily or by operation of law assign or otherwise transfer the obligations incurred on his part pursuant to the terms of this Agreement without the prior written consent of MusclePharm. Any attempted assignment or transfer by Endorser of his obligations without such consent shall be void.
15. Modification of Agreement: The parties may modify this Agreement hereto only by a written supplemental agreement executed by both parties.
16. Notice: Any notice required or permitted to be given hereunder shall be sufficient if given in writing, and sent by registered or certified mail, postage prepaid, or by courier such as FedEx, addressed as follows:
If to MusclePharm:
If to the Endorser:
MusclePharm
Attn: Brad Pyatt; CEO
4721 Ironton Street
Denver, CO 80237
With a copy to:
MusclePharm
Attn: Mark Campanini
General Counsel
401 N. Tryon St.; 10th Floor
Charlotte, NC 28202
Michael Vick
c/o Damien Butler
G³ Sports Marketing & Representation, LLC
1717 Dowling Drive
Irving, TX 75038
or to such other address as the parties hereto may specify, in writing, from time to time. Written notice given as provided in this paragraph shall be deemed received by the other party two business days after the date the mail is stamped registered or certified and deposited in the mail, or deposited with courier.
17. Governing Law: This Agreement has been executed and delivered in Denver County in the State of Colorado, and its interpretation, validity and performance shall be construed and enforced in accordance with the laws of the State of Colorado. Venue for any proceeding to interpret, construe or enforce this Agreement shall be Denver County, Colorado, whether such proceeding is in a court of competent jurisdiction or pursuant to mediation or arbitration proceedings.
18. Dispute Resolution: Any controversy, dispute or question arising under this Agreement shall be determined, if possible, by good faith mediation, arbitration or comparable alternative dispute resolution proceedings agreed to by the parties. In the event the parties cannot agree upon alternative dispute resolution procedures to resolve their disagreements, then either party may resort to litigation in a court of competent jurisdiction in Denver County, Colorado. In connection with any alternative dispute resolution proceedings, including mediation or arbitration, the parties shall share equally the cost and expense of the alternative dispute resolution proceeding, and each party shall be responsible for its own attorneys’ fees. In the event either party resorts to litigation, the provisions of Colorado law will govern the award of attorneys’ fees as a remedy.
19. Binding Effect: This Agreement when signed by the parties shall be binding upon the parties, and their respective heirs, successors or legal representatives.
20. Payments: All cash payments shall be made via wire transfer to the endorser to an account provided by endorser or his representative.
21. Trademarks: Nothing contained in this agreement shall be construed to convey to MusclePharm any right to use the trademarks, logos, team identifications, uniforms, or uniform numbers (“Marks”) of any professional, collegiate, or amateur football association and/or league (including any member clubs or teams of such association and/or league) including, but not limited to the NFL, any NFL Team, the NCAA, or any NCAA Team in conjunction with the services provided in this agreement. MusclePharm must acquire all rights to the use of such Marks from the appropriate rights holder.
22. Insurance: MusclePharm shall be responsible to provide for any appearance satisfactory evidence of self insurance or a certificate of insurance evidencing Commercial General Liability insurance in either case with coverage limits not less than $1,000,000 each occurrence. Such insurance shall be endorsed to name Endorser as Additional Insured with respect to claims arising out of Appearances.
23. Entire Agreement: This Agreement contains the entire contract of the parties with respect to the subject matter hereof and supersedes all agreements and understandings between the parties concerning the subject matter hereof. The language in all parts of this Agreement shall in every case be construed simply according to its fair meaning.
contact cont.
(e) During the term of this Agreement, Endorser shall participate in three (3) personal appearances (“Appearances”) or photo/video sessions (“Production Days”) per Contract Year. Appearances may be up to four (4) hours in length not including travel time to and from the appearance, as scheduled by MusclePharm, for the purpose or promoting MusclePharm and it’s Products. Production Days shall be for the purpose of MusclePharm obtaining a sufficient number of acceptable photographs and/or video footage of Endorser for the editorial and commercial uses intended by MusclePharm pursuant to this Agreement. Production days may be up to eight (8) hours in duration.
(f) Endorser may make additional personal appearances, at the request of MusclePharm, but the parties agree that Endorser shall have no specific duty or obligation to make more appearances, and that doing so will be a gesture of goodwill on the part of Endorser with compensation, if any, to be determined prior to Endorser making the additional appearances. None of Endorser’s appearances for MusclePharm, pursuant to this Agreement, shall be at events promoted as autograph or sports card shows.
(g) Endorser expressly represents and warrants that he is not subject to any restriction or limitation by way of employment or contractual obligation that may impair or limit his performance of the advertising and promotional activities described above, and that Endorser has the express approval of his present employer to make the promises and commitments set forth herein, and will advise any future employer of his obligations hereunder.
5. Scheduling: The Production Days, the interview of Endorser by MusclePharm, personal appearances, and all advertising and promotional activities requested by MusclePharm shall be scheduled by mutual agreement and with due consideration for Endorser’s other business activities and commitments occurring during the term of this Agreement. To the greatest extent practicable, Endorser’s commitments pursuant to this Agreement shall be scheduled during the off-season for professional football. Endorser agrees that he will in good faith make every reasonable effort, given his other commitments, to give priority to the fulfillment of his obligations pursuant to this Agreement. The parties shall confer periodically for the purpose of coordinating and scheduling Endorser’s advertising and promotional activities and services.
6. Right of Publicity: As provided below, Endorser expressly, exclusively and irrevocably grants to MusclePharm the right to use Endorser’s name, photograph, picture, appearance, or likeness, including video and other recordings of Endorser’s appearance, along with the right to use Endorser’s voice, including audio or other recordings of Endorser’s voice, Endorser’s signature, personal or professional background and experience, reputation, quotations and endorsements, or paraphrases of Endorser’s quotations and endorsements, or any other personal identification or identifying characteristics, however obtained, including touch-ups, simulations or compositions of any of the above whether generated by computer or by any other means, for the period of time and for the purposes set forth in this Agreement. Collectively, Endorser’s personal identifying characteristics, set forth in this paragraph, will be referred to as Endorser’s “Name and Appearance” and the rights Endorser grants to MusclePharm to use Endorser’s Name and Appearance will be referred to as the “Right of Publicity” or the “Rights to Publicize.”
(a) During the term of this Agreement, Endorser grants to MusclePharm and consents to MusclePharm’s unlimited commercial use of Endorser’s Name and Appearance, and the Rights to Publicize Endorser’s Name and Appearance, in MusclePharm’s sole discretion, to advertise, promote, endorse and publicize Products, and MusclePharm’s business, worldwide in any media selected by MusclePharm, including but not limited to print, radio, television, electronic, telephone, wireless or internet.
(b) Endorser also irrevocably grants to MusclePharm and consents to MusclePharm‘s unlimited editorial use of Endorser’s Name and Appearance in Company published materials. For purposes of this Agreement, MusclePharm’s editorial use of Endorser’s Name and Appearance shall mean a use that does not directly promote, advertise or endorse MusclePharm’s business or its Products.
(c) MusclePharm may in its sole discretion exercise some or all of the rights granted by Endorser in this Agreement, but MusclePharm shall have no obligation to exercise or use the rights Endorser has granted. If MusclePharm elects to not exercise or use all the rights granted by Endorser, MusclePharm’ election shall not be interpreted or construed as a waiver or release of such rights. MusclePharm shall have the rights to use Endorser’s Name and Appearance and the Right to Publicize Endorser’s Name and Appearance, as provided in this Agreement, unless Endorser and MusclePharm enter into a separate written agreement in which MusclePharm waives or releases some or all of the rights Endorser has granted in this Agreement.
(d) Endorser expressly represents and warrants that he is not subject to any restriction or limitation by way of employment or contractual obligation that may impair or limit the right of publicity granted herein by Endorser, and that Endorser has the express approval of his employer to make the promises and commitments set forth herein.
7. Compensation: As compensation for the endorsements and testimonials given by Endorser, and for his advertising and promotional activities, and for the right to publicize Endorser’s Name and Appearance, MusclePharm shall compensate Endorser as follows:
(a) Cash: During the term of this Agreement, MusclePharm shall pay Endorser $200,000 per Contract Year (for a total of $400,000 during the two year term). Payments shall be made in installments as follows:
$50,000 payable on each of the following dates:
First photo shoot (currently scheduled on or about July 20, 2011)
September 15, 2011
January 1, 2012
April 1, 2012
July 1, 2012
September 15, 2012
January 1, 2013
April 1, 2013
(b) Stock: During each Contract Year of this Agreement, MusclePharm shall issue Endorser $100,000 in MusclePharm restricted stock (“Stock”), for services performed. Stock will be valued based on the average closing price for the twenty (20) trading days prior to the date of issuance. Stock shall be issued in compliance with all SEC rules and regulations.
(c) Bonus Compensation: Endorser shall be paid performance bonus compensation as follows:
§
Endorser is selected for and plays in the Pro Bowl: $25,000 cash and $50,000 in Stock.
§
Endorser’s NFL team makes the playoffs: $25,000 cash and $50,000 in Stock.
§
Endorser wins the NFL Most Valuable Player Award: $50,000 cash
§
Endorser’s NFL team plays in the Super Bowl: $50,000 cash
(d) MusclePharm also shall provide a reasonable supply of Products and apparel for Endorser’s personal use and endorsement as contemplated by this Agreement.
8. Termination: This Agreement may be terminated by either party at any time upon mutual agreement in writing; or upon a material breach or default of this Agreement; or upon the death, disability or incapacity of Endorser:
(a) In the event either party desires to terminate this Agreement because of a material breach or default by the other party, the party seeking to terminate shall give written notice of intent to terminate to the other party, and in such notice shall set forth in reasonable detail the facts, circumstances or events causing the alleged breach or default (“Events of Default”). The party in default shall have thirty (30) days notice in which to cure the Events of Default to the reasonable and objective satisfaction of the terminating party. If the party in default fails, refuses or is unable for any reason to cure the Events of Default to the reasonable and objective satisfaction of the terminating party, then the terminating party may terminate this Agreement by giving a written termination notice which shall be effective on third calendar day after the date of the termination notice.
The whole endorsement agreement was attrached to the 8-k
ENDORSEMENT AGREEMENT
THIS AGREEMENT is entered into by and between Michael Vick, (“Endorser”) and MusclePharm Corporation with its principal place of business in Denver, Colorado, and its affiliated entities, (collectively, “MusclePharm” or the “Company”).
RECITALS
Whereas, MusclePharm is engaged in the business of developing and marketing nutritional products for athletes and fitness enthusiasts, and
Whereas, the full range of MusclePharm’s nutritional products and dietary supplements shall be referred to as “Products”, and
Whereas, MusclePharm from time to time uses consumer, celebrity, and expert endorsements or testimonials to promote MusclePharm Products in marketing and advertising materials, and
Whereas, MusclePharm desires to engage Endorser, and Endorser desires to accept the engagement, as more fully described in this Agreement, whereby Endorser will lend his name, reputation, and appearance to endorse and promote MusclePharm and its Products.
NOW, THEREFORE, in consideration of the mutual promises and agreements set forth below, the parties agree as follows:
1. Term: This Agreement shall have an initial term of two (2) years. The term shall commence on July 15, 2011 and shall expire on July 15, 2013, unless otherwise terminated earlier. The period from July 15, 2011 to July 14, 2012 shall be referred to as the “First Contract Year”. The period from July 15, 2012 to July 15 2013 shall be referred to as the “Second Contract Year”.
This Agreement may be renewed for an additional term of one year (“Third Contract Year”) by MusclePharm, in its sole discretion, with notice to Endorser by May 15, 2013. If this Agreement is renewed for an additional term, commencing July 15, 2013, the Agreement shall expire and terminate automatically without further notice on July 15, 2014. The terms and conditions of the renewal will be negotiated in good faith by the parties based on the criteria attached hereto as Exhibit “A”.
2. Engagement: MusclePharm hereby engages Endorser and Endorser promises and agrees to hold himself available to use, evaluate, advertise and promote certain MusclePharm Products, as may be requested by MusclePharm. Endorser also agrees to the use, during the term, of his name, photograph, appearance, likeness, reputation, voice, signature and other identifying characteristics, as more fully described below (Endorser’s appearance, voice and identifying characteristics, described in paragraph 6 below, shall be referred to as his “Name and Appearance”) to advertise and promote the business of MusclePharm and its Products.
3. Endorsement of Products: Endorser agrees that he will use and evaluate the Products according to the recommended use and dose guidelines. Based on Endorser’s knowledge, personal use and experience with the Products he shall from time to time during the term of this Agreement provide his honest evaluation, opinion, and findings about the Products he is endorsing and promoting. The endorsements must be based on Endorser’s knowledge and/or personal use and experience with the Products at or about the times the endorsements are made. Endorser’s statements and endorsements, or paraphrases thereof, may be used by MusclePharm to advertise, promote and publicize its business and Products as provided herein. Endorser’s endorsements of the Products will be in accordance with the guidelines established by the Federal Trade Commission for endorsements in advertising. If requested by MusclePharm, Endorser shall provide a signed affidavit in form satisfactory to MusclePharm confirming Endorser’s compliance with the FTC standards in connection with his endorsements and endorsement activities.
MusclePharm will use Endorser’s testimonials, endorsements, paraphrases thereof, and Endorser’s picture, likeness, facsimile signature or similar identifying characteristics, in association with the Products. This limitation applies to Endorsement of Products as well as to the Right of Publicity set forth at Paragraph 6 below.
4. Advertising and Promotional Activities: During the term of this Agreement the Endorser agrees to perform the following advertising and promotional services for MusclePharm:
(a) Endorser agrees that MusclePharm shall have the unlimited right to use, worldwide, Endorser’s Name and Appearance to advertise MusclePharm and its Products in print media, and in all other forms of media including, but not limited to, point of sale material, premiums and novelties, direct marketing material, and radio, television, electronic, and computer media (including but not limited to MusclePharm’s Internet and social media websites). Print media will also include promotional items on which Endorser’s picture; likeness, facsimile signature or similar identifying characteristics may appear (e.g., posters, footballs, jerseys, etc.). Endorser will have the right to approve, in writing via his representative’s office, print-advertising materials which utilize Endorser’s Name and Appearance, but Endorser will not unreasonably withhold approval and will promptly respond to all approval requests. In the event Endorser appears in television commercials promoting MusclePharm and its Products during the term hereof, and for the purpose of computing health and welfare benefit contributions and any other payments under any SAG or AFTRA contracts applicable to Endorser's appearance in such television commercials, then 25% of the compensation payable to Endorser under this Agreement shall be allocated as fair and reasonable consideration for Endorser's work and appearance in television commercials broadcast during the term or thereafter during the six month use-up period defined below.
MusclePharm also shall have the unlimited right to use, worldwide, Endorser’s oral or written endorsements of Products, or paraphrases thereof, to promote MusclePharm, its business, Products and publications.
The right to use Endorser's Name and Appearance granted to MusclePharm in this section shall extend for six (6) months beyond the expiration of this Agreement (the "Use-up Period"). MusclePharm shall create no new advertising during the Use-up Period using Endorser's Name and Appearance, but shall have the right to use during the Use-up Period Endorser's Name and Appearance in advertisements and promotional materials created before the expiration date of this Agreement.
(b) Endorser will aggressively promote MusclePharm via his websites (e.g. mikevick.com) and social media outlets (e.g. Facebook, Twitter and any future social media outlets used by Endorser; hereinafter collectively “Social Media”) on a regular basis. MusclePharm shall have the right to directly contact Endorser’s Social Media representatives for purposes of drafting statements for use on Endorser’s Social Media sites. Endorser’s Social Media representatives must respond to MusclePharm’s requests within two (2) hours during normal business hours (8:00 am to 7:00 pm Eastern Time). Requests made outside normal business hours shall receive a response by 8:00 am Eastern Time the following day.
For all Endorser’s websites and Social Media sites:
·
Endorser shall identify himself as a “MusclePharm Athlete” under his profile name and prominently display the MusclePharm logo.
·
Endorser shall provide a prominently placed link to musclepharm.com and any additional MusclePharm websites as may be requested by MusclePharm from time to time.
Endorser shall place a MusclePharm banner or advertisement selected by MusclePharm. Endorser shall have the right to approve the banner or advertisement; such approval shall not be unreasonably withheld.
Endorser shall create a Note page dedicated to MusclePharm and its Products on his Facebook page. Endorser shall be a follower of MusclePharm on Twitter and “Like” MusclePharm on Facebook.
Endorser will provide online content for MusclePharm’s websites and social media websites as requested by MusclePharm. This will be in a form agreed to by the parties (e.g. training video or video interview with a MusclePharm representative). This will be scheduled so as to not interfere with Endorser’s obligations to his team and the NFL.
(c)
Hey DEGH shareholders,
Fuse science wants you to tweet who you would like to see as their next Powered by FUSE athlete.
Oh by the way, DEGH longs news out on the Fuse website.
AVENTURA, Fla., July 27, 2011 - Double Eagle Holdings, Ltd (OTCQB: DEGH.pk), the parent company of Fuse Science, Inc. (www.fusescience.com) announced today that it has entered into endorsement partnerships with:
Super Bowl Champion Mike Neal of the Green Bay Packers, Pittsburgh Steelers playoff sensation Antonio Brown, and NFL First Round Draft picks:
* Tyron Smith, by the Dallas Cowboys,
* Derek Sherrod, by the Green Bay Packers, and
* Jimmy Smith by the Baltimore Ravens.
These agreements represent five major athletic partnerships in a series of endorsement deals which the Company expects to announce in the coming days and weeks. Fuse Science is the developer of new, proprietary technologies poised to redefine how consumers receive energy, medicines, vitamins and minerals.
“Success comes from hard work and dedication by a team of individuals who want to achieve something greater by working together” said Brian Tuffin, President and Chief Operating Officer. “The combination of exceptional talent dedicated to being their best and superior nutrition technology that naturally works faster, longer and stronger is what it means to be Powered by Fuse!”
When NFL Playoff Sensation, Antonio Brown was asked about his decision to join the Fuse team he stated, “Fuse Science offers me the opportunity to achieve better results naturally during work outs and on the playing field. With Fuse I can load electrolytes, help pain and muscle fatigue, and get the natural energy boosts I need in seconds that last… compared to conventional methods which can take half an hour or longer to begin to work”.
“Considering how long we have been waiting for a company to come out with solutions to allow athletes to load up before and during a game without having to wait 30 minutes for results, it’s no shock that FUSE will change the way guys in the league consume energy and electrolytes” said Derek Sherrod, 1st Round Pick for the super bowl champion Green Bay Packers. “For me it’s simple, easier and faster results, easy decision.”
“Just like I know my skills to dominate at the cornerback position are legit, I know that FUSE allows me to take it to another level without putting ingredients into my body I don’t need and I get results in seconds, versus minutes or hours” said Jimmy Smith, 1st Round Pick for the Baltimore Ravens.
Part of a skillfully developed strategy, the announcement of the signing of these five athletes is only the beginning of the “Powered by Fuse” movement. Negotiations are underway with star athletes in the National Basketball Association, The PGA Tour, Professional Tennis, Olympic Sports, and other professional sports organizations. We anticipate announcing these and other partnerships in the days ahead.
“We believe our proprietary technology has significant applications well beyond the sports nutrition and energy categories and our entire executive team is focused with this end in mind, added Tuffin. “This first step is part of a calculated strategy to introduce to the world the capabilities we possess, and this team of Athletes will do a great job showcasing what it means to me Powered by Fuse!”
“My rehab and workout regime is intense and the Fuse EnerJel product is helping to keep me on track like no other… Every second counts when you’re working to be the best!” Mike Neil, Super Bowl Champion!
Well squirrel let's have a math lesson really quick.
6 months ago to the date (1/27/2011) DEGH trade range was .0048-.015 (for those with equity feed you can verify). So for 1560.00 @.0048 gets you 325,000 shares.
Today date, a DEGH long, would be up about 97,500 dollars give or take a few pennies but who's counting. If they just so happened to get out at the .75 a cool 243,750 cash. And that's without a product on the shelf. Other companies have products to sell and are much more established and are actually down 90% or more. Could you please explain.
New pics on the fuse science page!!!!!! Antonio Brown and Brad Maynard.
Thanks Ulfahl,
I usually go to the sec filings website and sift through the filings for the stocks in researching or currently in.
If you go to sec filings website put in MusclePharm as the company and it list all sec filings for the company. Vick's full endorsement deal with mslp is there for viewing along with the 8-k, press releases and pics. As a potential shareholder, I wanted to know the terms of the agreement since MSLP posted it with the 8-k which I found unusual but ok. I am just puzzled as to how they will pay for the things that were listed if they are not showing a profit. Ex. on photoshoot day he recieved 50,000 in compensation. I'm in DEGH looking at taking a position here. Just still working on DD.
No the terms of that deal were undisclosed like his Nike deal. I was just inquiring if others read it and if it's common practice for endorsement contracts to be included in 8-k.
Has anyone read Mike's contract attached to the 8-k? Well it makes for a good read. Also is it common practice for endorsement contracts to be attached to 8-k's. I am in degh, but watching mslp as a possibility.
Has anyone read the contract MP posted with the 8-K. If anyone has the time it makes for a good read. Also is it common practice for companies to post full endorsement contracts in 8-k's.
Thanks for your response and good luck with MP.
Priceless, I am also looking into investing in MSLP and an earlier post from Firedog raised concerns about company revenue as related to pps. I am in DEGH and looking to move profits but have a few concerns with MSLP at the moment.First, I would question the validity of the information coming from a facebook and twitter page. I also see were shareholders are questioning the ceo about dilution. This is no way to handle business especially for potential shareholders. Im in DEGH due to the step wise fashion they have conducted business down to executing a spot on CNBC with Vick and Adler.
Jul 20, 2011 Michael Vick is Powered by Fuse!
Jul 14, 2011 Double Eagle Holdings Enters Into Supply Agreement with Platform Delivery Technologies Inc.
Jul 11, 2011 Fuse Science Oversubscribes First Round of Seed Capital
Jul 6, 2011 HR Division Head for Medical Giant Covidien Joins Advisory Board of Fuse Science, Inc.
Jun 29, 2011 Fuse Science Adds Renowned Duke University Team Physician to Board
Jun 15, 2011 Double Eagle Holdings Adds Former Vice President of Sales at Michelin to Corporate Advisory Board
Jun 14, 2011 Current Chief Marketing Officer at Alasko Foods and Former General Mills Executive Joins Double Eagle Advisory Board
Jun 8, 2011 Double Eagle Holdings Adds Former Bayer & Merck Executive to Advisory Board
Jun 6, 2011 Double Eagle Applies for OTC: Bulletin Board Listing
Jun 2, 2011 Former SC Johnson Worldwide Chief Technical Officer Joins Double Eagle Holdings Board
If I could get some insight into the current over all view of the company and it's vision in the future it would be appreciated as a potential investor. I have begun DD but facebook and twitter are not viable avenues for the money I would be willing to invest in MSLP.
Well Dumper, I would question the validity of the information coming from a facebook page. I also see were shareholders are questioning the ceo about dilution. This is no way to handle business especially for potential shareholders. Something else for you to ponder, Fuse didn't wake up yesterday decide to sign Vick and get a spot on CNBC in a few hours span and have him leave to sign with MusclePharm. If he did sign with MP then MP would have been quick to announce it. Fuse has strategically planned every move with precision down to securing a spot on CNBC with Vick.
Jul 20, 2011 Michael Vick is Powered by Fuse!
Jul 14, 2011 Double Eagle Holdings Enters Into Supply Agreement with Platform Delivery Technologies Inc.
Jul 11, 2011 Fuse Science Oversubscribes First Round of Seed Capital
Jul 6, 2011 HR Division Head for Medical Giant Covidien Joins Advisory Board of Fuse Science, Inc.
Jun 29, 2011 Fuse Science Adds Renowned Duke University Team Physician to Board
Jun 15, 2011 Double Eagle Holdings Adds Former Vice President of Sales at Michelin to Corporate Advisory Board
Jun 14, 2011 Current Chief Marketing Officer at Alasko Foods and Former General Mills Executive Joins Double Eagle Advisory Board
Jun 8, 2011 Double Eagle Holdings Adds Former Bayer & Merck Executive to Advisory Board
Jun 6, 2011 Double Eagle Applies for OTC: Bulletin Board Listing
Jun 2, 2011 Former SC Johnson Worldwide Chief Technical Officer Joins Double Eagle Holdings Board
With this group of individuals working for DEGH( Fuse Science ) ask yourself who is more business savy? It is also known in the sports world that different teams and companies court athletes, athletes just go with the better deal. 1.55 million or 5 year equity partner.
POSTED: July 21, 2011
Competing nutrition firms both touting Vick as their new spokesman
By MARCUS HAYES
Philadelphia Daily News
hayesm@phillynews.com
Michael Vick might be "Powered by Fuse," as the company's motto goes, but his re-entry into the endorsement game could be short-circuited.
Nothing concerning the infamous Eagles' quarterback is uncomplicated.
Yesterday, two sports nutrition companies issued statements that said Vick would represent their products.
Fuse Science, based in Miami, trumpeted an exclusive, 5-year deal with Vick, financial terms withheld.
One problem: Exclusive indicates Vick cannot have a deal with any similar company.
Last week, reports surfaced that Vick would hawk products for MusclePharm, an unwisely named company based in Denver. Indeed, MusclePharm yesterday issued a news release stating that Vick would receive $1.55 million over the next 3 years.
On its website, MusclePharm even posted photos of Vick apparently signing his deal with MusclePharm.
The folks at Fuse were not amused.
"That was all speculation," Liza Santana, a Fuse spokeswoman, said via email. "Michael's contract with . . . Fuse is a 5-year exclusive and was fully executed on July 7th."
Santana elaborated:
"I would say that he is well aware that signing any other deals would be a breach of contract."
Is he aware?
Multiple calls to Vick's attorney, Andrew Stroth, were not returned.
Mutiple calls to MusclePharm's representative were not returned.
Santana's "speculation" assertion implies that Fuse knew of Vick's negotiations with Muscle-Pharm and, perhaps, that there never was a finalized deal with MusclePharm.
Significantly, Vick is not quoted in the MusclePharm release. However, he went on Twitter to tout his arrangement. "I am very excited about working with @MusclePharm one of the hottest supplement companies on the market, and to b part of a strong roster." He also tweeted that he was taking part in a photo shoot for the company.
(However, in the release, company CEO Brad Pyatt pre-emptively, and perhaps unnecessarily, asserts his own love for dogs; Vick is 2 years removed from his prison term for dogfighting.)
Vick did offer a testimonial for the Fuse release:
"I believe these products will revolutionize how athletes provide their bodies with nutrients and medicines, changing what we have come to accept as normal. Why take a painkiller and wait 30 to 40 minutes for it to work, when a better product can work in one-tenth the time?"
Certainly, that quote indicates a conscious allegiance with Fuse and its cadre of alchemists.
Unlike MusclePharm, Fuse did not address Vick's association with dogfighting and animal torture.
Assuming Vick has a real deal with at least one of the sports nutrition companies, it would be his second significant deal since re-entering the NFL in 2009 with the Eagles after missing two seasons because of the dogfighting conviction.
Vick's first endorsement deal, announced earlier this month, was with Nike . . . assuming he already doesn't have a deal with adidas.
Fuse also indicated Vick is the first of several athletes who will be coming aboard to shill for their potions.
That is, as long as they don't stop by the MusclePharm first. *
Read more: http://www.philly.com/philly/sports/20110721_Competing_nutrition_firms_both_touting_Vick_as_their_new_spokesman.html#ixzz1SmSmRDR9
Watch sports videos you won't find anywhere else
OK Hart if marketing is key, then why would Puresheets advertise through WSOP? How much energy does it take to ask for cards from a dealer? Do the players get tired from holding the cards? Really how much energy does one need to play cards to the end? I'm only asking because I don't play cards, but it sounds like if poker playing takes that much energy then Powered by FUSe may be the way to go. All in my humble opinion.